Assessing carrageenan-induced locomotor activity impairment in rats: Comparison with evoked endpoint of acute inflammatory pain

European Journal of Pain (United Kingdom)

Volumn 16, Issue 6, 2012, Pages 816-826

  Zhu, C Z ^a   Mills, C D ^a   Hsieh, G C ^a   Zhong, C ^a   Mikusa, J ^a   Lewis, L G ^a   Gauvin, D ^a   Lee, C H ^a   Decker, M W ^a   Bannon, A W ^a   Rueter, L E ^a   Joshi, S K ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CARRAGEENAN; DICLOFENAC; DULOXETINE; GABAPENTIN; IBUPROFEN; MORPHINE; SODIUM CHLORIDE;

ANALGESIA; ANIMAL MODEL; ARTICLE; CARRAGEENAN INDUCED LOCOMOTOR ACTIVITY IMPAIRMENT; DOSE RESPONSE; DRUG EFFICACY; EVOKED RESPONSE; HYPERALGESIA; INFLAMMATORY PAIN; LIGHT INTENSITY; LOCOMOTION; MALE; MOTOR DYSFUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ACUTE PAIN; ADRENERGIC UPTAKE INHIBITORS; AMINES; AMPHETAMINE; ANALGESICS; ANALGESICS, OPIOID; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BEHAVIOR, ANIMAL; CARRAGEENAN; CENTRAL NERVOUS SYSTEM STIMULANTS; CYCLOHEXANECARBOXYLIC ACIDS; DICLOFENAC; DISEASE MODELS, ANIMAL; GAMMA-AMINOBUTYRIC ACID; HYPERALGESIA; IBUPROFEN; LAMENESS, ANIMAL; MALE; MORPHINE; MOTOR ACTIVITY; NEURITIS; RATS; RATS, SPRAGUE-DAWLEY; THIOPHENES;

EID: 84867730789     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1002/j.1532-2149.2011.00099.x     Document Type: Article

References (30)

1. Boyce-Rustay JM, Zhong C, Kohnken R, Baker SJ, Simler GH, Wensink EJ, et al. Comparison of mechanical allodynia and the affective component of inflammatory pain in rats. Neuropharmacology 2010;58:537-43.
2. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994;53:55-63.
3. Davidson M, de Morton N. A systematic review of the Human Activity Profile. Clin Rehabil 2007;21:151-62.
4. Farrell MJ, Gerontol M, Gibson SJ, Helme RD. The effect of medical status on the activity level of older pain clinic patients. J Am Geriatr Soc 1995;43:102-7.
5. Guay J, Bateman K, Gordon R, Mancini J, Riendeau D. Carrageenan-induced paw edema in rat elicits a predominant prostaglandin E2 (PGE2) response in the central nervous system associated with the induction of microsomal PGE2 synthase-1. J Biol Chem 2004;279:24866-72.
6. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988;32:77-88.
7. Horrigan JP, Barnhill LJ. Low-dose amphetamine salts and adult attention-deficit/hyperactivity disorder. J Clin Psychiatry 2000;61:414-7.
8. Houghton AK, Kadura S, Westlund KN. Dorsal column lesions reverse the reduction of homecage activity in rats with pancreatitis. Neuroreport 1997;8:3795-800.
9. Iwamoto ET. An assessment of the spontaneous activity of rats administered morphine, phencyclidine, or nicotine using automated and observational methods. Psychopharmacology (Berl) 1984;84:374-82.
10. Iyengar S, Webster AA, Hemrick-Luecke SK, Xu JY, Simmons RM. Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats. J Pharmacol Exp Ther 2004; 311:576-84.
11. Jones CK, Peters SC, Shannon HE. Efficacy of duloxetine, a potent and balanced serotonergic and noradrenergic reuptake inhibitor, in inflammatory and acute pain models in rodents. J Pharmacol Exp Ther 2005;312:726-32.
12. Joshi SK, Hernandez G, Mikusa JP, Zhu CZ, Zhong C, Salyers A, et al. Comparison of antinociceptive actions of standard analgesics in attenuating capsaicin and nerve-injuryinduced mechanical hypersensitivity. Neuroscience 2006; 143:587-96.
13. Langford DJ, Bailey AL, Chanda ML, Clarke SE, Drummond TE, Echols S, et al. Coding of facial expressions of pain in the laboratory mouse. Nat Methods 2010;7:447-9.
14. Larsen JJ, Arnt J. Reduction in locomotor activity of arthritic rats as parameter for chronic pain: effect of morphine, acetylsalicylic acid and citalopram. Acta Pharmacol Toxicol (Copenh) 1985;57:345-51.
15. Lu Y, Westlund KN. Gabapentin attenuates nociceptive behaviors in an acute arthritis model in rats. J Pharmacol Exp Ther 1999;290:214-9.
16. Martin TJ, Buechler NL, Kahn W, Crews JC, Eisenach JC. Effects of laparotomy on spontaneous exploratory activity and conditioned operant responding in the rat: a model for postoperative pain. Anesthesiology 2004;101:191-203.
17. Matson DJ, Broom DC, Carson SR, Baldassari J, Kehne J, Cortright DN. Inflammation-induced reduction of spontaneous activity by adjuvant: a novel model to study the effect of analgesics in rats. J Pharmacol Exp Ther 2007; 320:194-201.
18. Mazurski EJ, Beninger RJ. Stimulant effects of apomorphine and (+)-amphetamine in rats with varied habituation to test environment. Pharmacol Biochem Behav 1988; 29:249-55.
19. McCleane G. Pharmacological strategies in relieving neuropathic pain. Expert Opin Pharmacother 2004;5:1299-312.
20. Mills CD, Grady JJ, Hulsebosch CE. Changes in exploratory behavior as a measure of chronic central pain following spinal cord injury. J Neurotrauma 2001;18: 1091-105.
21. Mishra BK, Wu T, Belfer I, Hodgkinson CA, Cohen LG, Kiselycznyk C, et al. Do motor control genes contribute to interindividual variability in decreased movement in patients with pain? Mol Pain 2007;3:20.
22. Piesla MJ, Leventhal L, Strassle BW, Harrison JE, Cummons TA, Lu P, et al. Abnormal gait, due to inflammation but not nerve injury, reflects enhanced nociception in preclinical pain models. Brain Res 2009;1295:89-98.
23. Randall LO, Selitto JJ. A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther 1957;111:409-19.
24. Reyes G, Medina R, Castillo EF, Herrera JE, Tinajero J, Chaves F, et al. On the analgesic effect of sodium diclofenac in pain-induced functional impairment in the rat. Proc West Pharmacol Soc 1998;41:149-50.
25. Reyes-Garcia G, Medina-Santillan R, Teran-Rosales F, Mateos-Garcia E, Castillo-Henkel C. Characterization of the potentiation of the antinociceptive effect of diclofenac by vitamin B complex in the rat. J Pharmacol Toxicol Methods 1999;42:73-7.
26. Roughan JV, Flecknell PA. Behavioural effects of laparotomy and analgesic effects of ketoprofen and carprofen in rats. Pain 2001;90:65-74.
27. Tianmei S, Knadler MP, Lim MT, Yeo KP, Teng L, Liang S, et al. Pharmacokinetics and tolerability of duloxetine following oral administration to healthy Chinese subjects. Clin Pharmacokinet 2007;46:767-75.
28. Torres-Lopez JE, Lopez-Munoz FJ, Castaneda-Hernandez G, Flores-Murrieta FJ, Granados-Soto V. Pharmacokineticpharmacodynamic modeling of the antinociceptive effect of diclofenac in the rat. J Pharmacol Exp Ther 1997; 282:685-90.
29. Whiteside GT, Harrison J, Boulet J, Mark L, Pearson M, Gottshall S, et al. Pharmacological characterisation of a rat model of incisional pain. Br J Pharmacol 2004;141:85-91.
30. Yokoyama K, Kurihara T, Makita K, Tanabe T. Plastic change of N-type Ca channel expression after preconditioning is responsible for prostaglandin E2-induced long-lasting allodynia. Anesthesiology 2003;99:1364-70.